|1.||Liu, Jun-Tian: 2 articles (12/2011 - 06/2007)|
|2.||Mao, Jun-Jun: 1 article (12/2011)|
|3.||Zhang, Ying: 1 article (12/2011)|
|4.||Li, Ming: 1 article (12/2011)|
|5.||Han, Chun-Jie: 1 article (12/2011)|
|6.||Pang, Xiao-Ming: 1 article (12/2011)|
|7.||Wang, Shui-hua: 1 article (08/2008)|
|8.||Wang, Guo-bin: 1 article (08/2008)|
|9.||Deng, Hong-tao: 1 article (08/2008)|
|10.||Xiao, Xiang-Hua: 1 article (06/2007)|
11/01/2006 - "To study the effects of the divided functional recipes of Dahuang Zhechong pill( DHZCP) on atherosclerosis in rabbits. "
12/01/2011 - "To study the mechanism of Dahuang Zhechong pill (DHZCP) against atherosclerosis induced by balloon angioplasty in rabbits. "
12/01/2011 - "[Mechanism of Dahuang Zhechong pill against atherosclerosis induced by balloon angioplasty in rabbits]."
|2.||Chronic Kidney Failure (Chronic Renal Failure)
08/01/2008 - "To assess the impact of Paidu Baoshen Pill (PBP, modified Dahuang Zhechong Pill), in retarding the procession of chronic renal failure (CRF) of stage II-III. The 283 patients of CRF stage II-III were randomly assigned to two groups, 151 patients in the treatment group treated with oral administration of PBP 3 g twice a day, and 132 patients in the control group with oxidative amylase aldehyde enveloped capsule 5-10 capsules thrice a day after meal. "
|4.||Cardiovascular Diseases (Cardiovascular Disease)